Untreated PKU patients without intellectual disability: SHANK gene family as a candidate modifier
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Untreated PKU patients without intellectual disability: SHANK gene family as a candidate modifier
Authors
Keywords
Phenylketonuria, Late-diagnosed, Untreated, Intellectual disability, Modifier gene, SHANK
Journal
Molecular Genetics and Metabolism Reports
Volume 29, Issue -, Pages 100822
Publisher
Elsevier BV
Online
2021-11-19
DOI
10.1016/j.ymgmr.2021.100822
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Drug Repurposing for Rare Diseases
- (2021) Helen I. Roessler et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Highly accurate protein structure prediction with AlphaFold
- (2021) John Jumper et al. NATURE
- Metabolic control during the neonatal period in phenylketonuria: associations with childhood IQ
- (2021) Geertje B. Liemburg et al. PEDIATRIC RESEARCH
- Phenylketonuria
- (2021) Francjan J. van Spronsen et al. Nature Reviews Disease Primers
- White matter disturbances in phenylketonuria: Possible underlying mechanisms
- (2020) Bruna Klippel Ferreira et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Generation of two hiPSC lines from a patient with autism spectrum disorder harboring a 120 kb deletion in SHANK2 and two control lines from each parent
- (2020) Flavia-Bianca Cristian et al. Stem Cell Research
- Human VPS13A is associated with multiple organelles and influences mitochondrial morphology and lipid droplet motility
- (2019) Wondwossen M Yeshaw et al. eLife
- Untreated PKU Patients without Intellectual Disability: What Do They Teach Us?
- (2019) Danique van Vliet et al. Nutrients
- SHANK genes in autism: Defining therapeutic targets
- (2018) Adele Mossa et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Can untreated PKU patients escape from intellectual disability? A systematic review
- (2018) Danique van Vliet et al. Orphanet Journal of Rare Diseases
- SHANK proteins: roles at the synapse and in autism spectrum disorder
- (2017) Patricia Monteiro et al. NATURE REVIEWS NEUROSCIENCE
- Exome arrays capture polygenic rare variant contributions to schizophrenia
- (2016) A. L. Richards et al. HUMAN MOLECULAR GENETICS
- Protective variant for hippocampal atrophy identified by whole exome sequencing
- (2015) Kwangsik Nho et al. ANNALS OF NEUROLOGY
- Phenylalanine induces oxidative stress and decreases the viability of rat astrocytes: possible relevance for the pathophysiology of neurodegeneration in phenylketonuria
- (2015) Thales Preissler et al. METABOLIC BRAIN DISEASE
- The Phyre2 web portal for protein modeling, prediction and analysis
- (2015) Lawrence A Kelley et al. Nature Protocols
- The emerging role ofSHANKgenes in neuropsychiatric disorders
- (2013) Audrey Guilmatre et al. Developmental Neurobiology
- Oxidative Stress in Phenylketonuria: What is the Evidence?
- (2011) Graziela S. Ribas et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation
- (2010) Simone Berkel et al. NATURE GENETICS
- Brain dysfunction in phenylketonuria: Is phenylalanine toxicity the only possible cause?
- (2009) F. J. van Spronsen et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Adults with late diagnosed PKU and severe challenging behaviour: a randomised placebo-controlled trial of a phenylalanine-restricted diet
- (2009) P J Lee et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Pathogenesis of cognitive dysfunction in phenylketonuria: Review of hypotheses☆
- (2009) M.J. de Groot et al. MOLECULAR GENETICS AND METABOLISM
- Human Genome Sequencing Using Unchained Base Reads on Self-Assembling DNA Nanoarrays
- (2009) R. Drmanac et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started